Drug Delivery Devices Market to Hit $698B by 2031, Driven by Smart and Wearable Tech
Event summary
- The global drug delivery devices market is projected to grow from $488.6B in 2026 to $698.2B by 2031, a CAGR of 7.4%.
- Growth is driven by rising prevalence of chronic diseases like diabetes, respiratory illnesses, and cancer.
- Smart and wearable drug delivery devices are expanding, integrating sensors and digital interfaces for better patient management.
- Inhalers led the market by product type in 2025, capturing approximately 24% share.
- Diabetes held the largest share by application type in 2025, supported by strong demand for insulin pumps and pens.
The big picture
The drug delivery devices market is evolving beyond simple dose administration, with smart and wearable technologies reshaping chronic disease management. The rise of biologics and complex therapeutics is creating demand for specialized delivery systems, while the expansion of home healthcare is driving innovation in user-friendly, connected devices. North America leads the market, but Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure development and increasing adoption of advanced pharmaceutical innovations.
What we're watching
- Technological Integration
- How the integration of sensors and digital interfaces will enhance patient adherence and clinical oversight.
- Regional Expansion
- Whether Asia-Pacific can sustain its rapid growth driven by expanding healthcare infrastructure and rising chronic disease prevalence.
- Strategic Partnerships
- The pace at which device manufacturers and pharmaceutical companies will collaborate to expand access to GLP-1 and biologic therapies.
Related topics
